By The Numbers
- Money-Making Mood Stabilizers
- No Product Revenues, Plenty of Risk: Buy Exelixis?
- Lightning Round: Caterpillar, Starbucks, Intel and More
- Lightning Round OT: SanDisk, Marvel Entertainment and More
- The Discounter’s Dilemma
- Cramer: Earnings, IPOs Dominate Next Week’s Game Plan
- Web Extra: The Final Trade
- Buying Fear: How to Own Volatility
- Burned by A&F, Alcoa & More
- Food Network, HGTV Drive Scripps Networks' Upside Surprise
RSS FEED
Text Size 
The futures are down again this morning with uncertainty of the impact that the swine flu will ultimately have. So far, nearly 150 people have died in Mexico from the disease as it continues to spread around the world including over 50 cases in the US.
Traders are focused on the short term gains they can make from the slow down in global commerce and tourism. They are also looking at the potential lift that pharmaceuticals and biotechs focusing on vaccinations may see. Switzerland's Novartis [NVS
Loading...
()
], for example, announced it has received the genetic code for the swine flu. Other companies that make flu vaccines include Sanofi-Aventis [SNY
Loading...
()
], GlaxoSmithKline [GSK
Loading...
()
], and Baxter International [BAX
Loading...
()
].
Here are some of the stocks that moved most yesterday as the story has developed.
 |
Comments? Send them to
- Rumors abound that Oprah will leave her show to start a new network. What would this mean for daytime TV?
- Berkeley's Chez Panisse and the trend of eating locally grown, pesticide-free seasonal foods.
- Cramer did the research and found eight stocks that lead the pack. Read on to get his top picks.
- Did Hideki Matsui’s performance make it more likely that the Yankees will pay to have him back?
- Which wines should you bring—or serve—with holiday meals this year? Ask a connoisseur.
- Two competitors in this year’s World Series of Poker in Las Vegas have stories fit for Hollywood.
Data is a real-time snapshot *Data is delayed at least 15 minutes